On April 29, 2021, the European Commission (EC) opened the debate on the regulatory status of New Genomic Techniques (NGTs) in the European Union (EU) by publishing a position paper[1].
Contrary to the position of the pharmaceutical industry, the procedures of forced transfer of licences should not be treated as a violation of patent rights, as they are, to a
In the midst of the Farm to Fork (F2F) debate and the renegotiation of the Common Agricultural Policy (CAP), the European Scientist gives the floor to Pierre Pagesse, one of
The expected report of the European Commission on “new genomic techniques” was published as announced before the end of April 2021. It represents an attempt for an “at the same
Summary: Like after the Second World War, we face today once again a choice between freedom and totalitarianism, namely between an open society that recognizes every human being as a
This piece is written by three experts who are part of the heads of two European associations, the WGG (Wissenschaftlerkreis Grüne Gentechnik e.V) in Germany and the AFBV (Association Française
A review of Jennifer Thomson’s book “GM Crops and the Global Divide” (CSIRO Publishing, 2020) by Kathleen L. Hefferon and Henry I. Miller Jennifer Thomson’s excellent new book, “GM Crops and
Samuel Furfari[a] and Henri Masson[b] review the possibilities allowed by hydrogen and the EU’s policies The enthusiasm for hydrogen Hydrogen suddenly seems to have become an exceptional solution for the
Bill Gates: a great disappointment There is no doubt that Bill Gates is one of the people who has made and keeps making a difference in our time. His creation
Go to the part 1 Does greater prior exposure to pathogens, including other recent coronaviruses, help explain why Africa is a COVID-19 cold spot, despite endemic poverty and a woeful